Introduction The WHO recommends human papillomavirus (HPV) cervical self-sampling as
an additional screening method and HPV DNA testing as an effective approach for the early …

Abstract Background Women living in Africa experience the highest burden of cervical
cancer. Research and investment to improve vaccination, screening, and treatment efforts …

Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Several countries offer HPV self-sampling for screening non-attendees. It is assumed that
screening attendees also prefer self-sampling to clinician-based sampling, however, little …

Background While the evidence for the clinical effectiveness of most noncommunicable
disease (NCD) prevention and treatment interventions is well established, care delivery …

Background Data is needed about barriers to self-collection of Human Papillomavirus (HPV)
samples and cytology among low-income, disadvantaged women living in rural areas of …

Background In the context of WHO's “task shifting” project and growing global consensus on
primary HPV-based cervical cancer screening, self-sampling is a promising new tool to …

Background: Cervical cancer is one of the most common cancers in women and about 90%
of cervical cancer can be reduced by regular screening. The Pap smear has been well in …

Objectives Self-sampling may increase access to cervical cancer screening in low-resource
settings. Using Xpert HPV, we compared test performance of self-and clinician-collected …

In a cross-sectional study carried out in El Salvador between February 2016 and July 2017,
self-sampling and human papillomavirus (HPV) testing was found to be highly acceptable …